Tesa Medical is an Orthopaedic Sports Medicine Company focused on enabling surgeons to precisely tension and fixate soft tissue during repair and reconstruction procedures. Tesa frees the surgeon’s hands to make dynamic assessments of joint stability and tension so the surgeon can see the finished result before deploying the proprietary fixation devices. Tesa’s enterprise software solution enables surgeons to build and access global patient data to make informed decisions before, during and after the procedure. The Tesa platform will optimize patient outcomes, reduce risk of revision surgery, and improve the patients ability to return to their prior level of activity. Supported by a world class Scientific Advisory Board, development partners Cor Medical Ventures and Savi Medical, Tesa is currently completing FDA submission for our Alpha launch platform by the end of 2024.